TSX News -
Enthusiast’s Luminosity Hosts Get On My Level X to Over 200,000 Unique Online Viewers
LOS ANGELES, June 03, 2024 (GLOBE NEWSWIRE) — Enthusiast Gaming Holdings Inc. (“Enthusiast Gaming” or the “Company”) (TSX: EGLX), a […]
TSX News -
Talisker Provides Update on the Second Draw on the US$31,250,000 Financing with Sprott Streaming and Royalty for the Bralorne Gold Project
TORONTO, June 03, 2024 (GLOBE NEWSWIRE) — Talisker Resources Ltd. (“Talisker” or the “Company”) (TSX: TSK, OTCQX: TSKFF) is pleased […]
TSX News -
Colliers to Acquire Leading Canadian Engineering Firm Englobe
TORONTO and LAVAL, June 03, 2024 (GLOBE NEWSWIRE) — Global diversified professional services and investment management company, Colliers (NASDAQ, TSX: […]
ATHA Energy Commences 2024 Angilak Diamond Drilling Exploration Program
HIGHLIGHTS: Angilak Project: The Angilak Project is host to the Lac 50 Uranium Deposit, which is one of the largest […]
Stallion Uranium Closes Sale of Non-Core Uranium Projects in Eastern Athabasca Basin
VANCOUVER, British Columbia, June 03, 2024 (GLOBE NEWSWIRE) — Stallion Uranium Corp. (the “Company” or “Stallion”) (TSX-V: STUD; OTCQB: STLNF; […]
Lithium Drilling Program Commences at East Vallée
TORONTO, June 03, 2024 (GLOBE NEWSWIRE) — Consolidated Lithium Metals Inc. (TSXV: CLM | OTCQB: JORFF | FRA: Z36) (“CLM” […]
Osisko Development to Complete Second Deferred Payment Installment in Connection With the Tintic Acquisition
MONTREAL, June 03, 2024 (GLOBE NEWSWIRE) — Osisko Development Corp. (NYSE: ODV, TSXV: ODV) (“Osisko Development” or the “Company“) announces […]
Whitestone REIT Continues Board Refreshment
Announces Board Leadership Changes Intends to Add Two New Trustees HOUSTON, June 03, 2024 (GLOBE NEWSWIRE) — Whitestone REIT (NYSE: […]
iBio Closes Sale of Manufacturing Facility in Texas
– The sale of the facility eliminates $13.2M of secured debt – – Completes iBio’s transition to an AI and precision biologics […]
Century Therapeutics Presents Interim Results from Phase 1 ELiPSE-1 Study at ASCO 2024 Annual Meeting
In ongoing dose escalation, CNTY-101 has demonstrated a manageable safety profile with no observed DLTs or GvHD and with majority […]
